Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients.
暂无分享,去创建一个
K. Johny | M. P. Nair | I. al-Muzairai | M. Nampoory | W. El-Reshaid | M. Al-Mousawi | V. Ninan | M. Samhan | J. N. Costandi | M. Abdulhalim